Orphan drugs refer to medications designated by regulatory authorities, such as the Ministry of Food and Drug Safety (MFDS) in South Korea, for specific rare conditions. These include:Drugs used to diagnose or treat rare diseases under the Rare Disease Management Act.Medications for conditions with no alternatives or significantly improved safety/effectiveness compared to existing options.Criter..